IGM Biosciences, Inc.
IGM Biosciences, Inc. (IGMS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IGMS · as of Jun 9, 2026
Key Statistics
Explore IGM Biosciences, Inc. Data
igms stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 44.4%
The IGMS analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $16.79, representing +1222.05% upside from the current price of $1.27.
Competitors & Peers
igms competitorsIGMS
ACHL
BLI
HTBX
IMDX
JBIOStock Performance
Full HistoryAbout IGM Biosciences, Inc.
IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, …
what is igm biosciences, inc. · igms stock overview · igm biosciences, inc. company profile · who is igm biosciences, inc. ceo · igms NASDAQ · igm biosciences, inc. headquarters · igm biosciences, inc. business segments
About Stock Overview & Key Data
IGM Biosciences, Inc. (IGMS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 18, 2019. As of the latest trading session, IGMS stock price is $1.27, with a market capitalization of $77.5M. The stock has returned -89.67% over the past 12 months and -79.55% year-to-date.
According to 18 Wall Street analysts, the consensus rating for IGM Biosciences, Inc. stock is Hold, with an average 12-month price target of $16.79. In fiscal year 2024, IGM Biosciences, Inc. reported revenue of $2.7M and net income of -$195.8M. For detailed data — including IGM Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IGM Biosciences, Inc. (IGMS) stock price is $1.27. The stock is traded on NASDAQ under the ticker symbol IGMS. The 52-week range is $0.92 – $22.50.